Suppr超能文献

De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.

作者信息

Hwang E Shelley, Solin Lawrence

机构信息

Duke Cancer Institute and Duke University Health System, Durham, NC.

Department of Radiation Oncology, Perelman Center for Advanced Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.

出版信息

J Clin Oncol. 2020 Jul 10;38(20):2230-2239. doi: 10.1200/JCO.19.02888. Epub 2020 May 22.

Abstract
摘要

相似文献

1
De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.
J Clin Oncol. 2020 Jul 10;38(20):2230-2239. doi: 10.1200/JCO.19.02888. Epub 2020 May 22.
3
Breast cancer: non-metastatic.
Clin Evid. 2002 Jun(7):1603-30.
5
Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?
Surg Oncol Clin N Am. 2018 Jan;27(1):69-80. doi: 10.1016/j.soc.2017.08.002.
6
Overall survival is improved when DCIS accompanies invasive breast cancer.
Sci Rep. 2019 Jul 9;9(1):9934. doi: 10.1038/s41598-019-46309-2.
7
Breast cancer: non-metastatic.
Clin Evid. 2002 Dec(8):1811-39.
9
Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.
Int J Surg. 2019 Mar;63:98-106. doi: 10.1016/j.ijsu.2019.01.016. Epub 2019 Feb 6.
10
ASO Author Reflections: Active Surveillance for Ductal Carcinoma In Situ (DCIS).
Ann Surg Oncol. 2020 Oct;27(11):4466-4467. doi: 10.1245/s10434-020-08637-w. Epub 2020 May 21.

引用本文的文献

1
An early economic evaluation of active surveillance for low-risk ductal carcinoma .
Future Oncol. 2024 Dec;20(40):3451-3462. doi: 10.1080/14796694.2024.2421152. Epub 2024 Dec 16.
3
Ductal carcinoma in situ and cause-specific mortality among younger and older postmenopausal women: the Women's Health Initiative.
Breast Cancer Res Treat. 2024 Aug;207(1):65-79. doi: 10.1007/s10549-024-07327-5. Epub 2024 May 11.
4
Tools to Guide Radiation Oncologists in the Management of DCIS.
Healthcare (Basel). 2024 Apr 6;12(7):795. doi: 10.3390/healthcare12070795.
6
Oncological safety of active surveillance for low-risk ductal carcinoma in situ - a systematic review and meta-analysis.
Ir J Med Sci. 2023 Aug;192(4):1595-1600. doi: 10.1007/s11845-022-03157-w. Epub 2022 Sep 16.
7
Addressing the problem of overtreatment in breast cancer.
Expert Rev Anticancer Ther. 2022 May;22(5):535-548. doi: 10.1080/14737140.2022.2064277. Epub 2022 May 19.
10
Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ.
J Clin Oncol. 2021 Jul 20;39(21):2386-2396. doi: 10.1200/JCO.21.00831. Epub 2021 May 21.

本文引用的文献

2
Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions.
Curr Oncol Rep. 2019 Mar 5;21(4):33. doi: 10.1007/s11912-019-0777-3.
3
Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
J Natl Cancer Inst. 2019 Sep 1;111(9):952-960. doi: 10.1093/jnci/djy220.
5
A Biological Signature for Breast Ductal Carcinoma to Predict Radiotherapy Benefit and Assess Recurrence Risk.
Clin Cancer Res. 2018 Dec 1;24(23):5895-5901. doi: 10.1158/1078-0432.CCR-18-0842. Epub 2018 Jul 27.
7
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.
9
Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):23-37. doi: 10.1016/j.ijrobp.2017.08.025.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验